Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Releases RNA Capture Product for Targeted Transcriptome Profiling


This article was originally published Feb. 2.

Expanding its SureSelect capture technology from genomic DNA to RNA, Agilent Technologies last week released SureSelect RNA Capture Kits for targeted transcriptome analysis.

The new kits will enable researchers to measure expression levels of genes of interest rather than the entire transcriptome, and to detect allele-specific expression, splice events, and gene fusions. Agilent developed the RNA capture product in conjunction with researchers led by Joshua Levin at the Broad Institute as part of an ongoing collaboration with the institute.

Agilent offers custom and catalog SureSelect kits for RNA capture to enrich gene products ranging from less than 200 kilobases to 6.8 megabases in total. Kits come in sizes from five to 10,000 reactions.

The company also provides SureSelect Human Kinome kits for RNA to analyze kinases and kinase-regulated genes.

The kits are optimized for several next-generation sequencing platforms, including the Illumina HiSeq and Genome Analyzer, and the Life Tech SOLiD. Samples can be indexed for multiplex sequencing, and the reagents are compatible with automation.

Agilent plans to add automation protocols for RNA capture on its Bravo automated liquid handling system in the near future.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.